Skip to content
Psychiatry

Publications (Esa Leinonen)

2020

Search PubMed

2019

Search PubMed

2018

  1. Pitkänen, A, Alanen, HM, Kampman, O, Leinonen, E. Outcome of neuropsychiatric symptoms and daily functioning of patients with dementia treated on an acute psychogeriatric ward. Nord J Psychiatry. 2018;72 (7):521-525. doi: 10.1080/08039488.2018.1532021. PubMed PMID:30445895 .
  2. Parviainen, HM, Halava, H, Leinonen, EVJ, Kosunen, E, Rannisto, PH. Successful Curriculum Change in Health Management and Leadership Studies for the Specialist Training Programs in Medicine in Finland. Front Public Health. 2018;6 :271. doi: 10.3389/fpubh.2018.00271. PubMed PMID:30298126 PubMed Central PMC6160571.
  3. Järvenpää, S, Peltola, J, Rainesalo, S, Leinonen, E, Lehtimäki, K, Järventausta, K et al.. Reversible psychiatric adverse effects related to deep brain stimulation of the anterior thalamus in patients with refractory epilepsy. Epilepsy Behav. 2018;88 :373-379. doi: 10.1016/j.yebeh.2018.09.006. PubMed PMID:30290977 .
  4. Sorri, A, Järventausta, K, Kampman, O, Lehtimäki, K, Björkqvist, M, Tuohimaa, K et al.. Effect of electroconvulsive therapy on brain-derived neurotrophic factor levels in patients with major depressive disorder. Brain Behav. 2018;8 (11):e01101. doi: 10.1002/brb3.1101. PubMed PMID:30273985 PubMed Central PMC6236235.
  5. Luoto, KE, Lindholm, LH, Paavonen, V, Koivukangas, A, Lassila, A, Leinonen, E et al.. Behavioral activation versus treatment as usual in naturalistic sample of psychiatric patients with depressive symptoms: a benchmark controlled trial. BMC Psychiatry. 2018;18 (1):238. doi: 10.1186/s12888-018-1820-x. PubMed PMID:30049272 PubMed Central PMC6063001.
  6. Paavonen, V, Luoto, K, Lassila, A, Leinonen, E, Kampman, O. Temperament clusters associate with anxiety disorder comorbidity in depression. J Affect Disord. 2018;236 :252-258. doi: 10.1016/j.jad.2018.04.084. PubMed PMID:29751240 .
  7. Paavonen, V, Luoto, K, Lassila, A, Leinonen, E, Kampman, O. Temperament and character profiles are associated with depression outcome in psychiatric secondary care patients with harmful drinking. Compr Psychiatry. 2018;84 :26-31. doi: 10.1016/j.comppsych.2018.04.001. PubMed PMID:29677572 .
  8. Sorri, A, Järventausta, K, Kampman, O, Lehtimäki, K, Björkqvist, M, Tuohimaa, K et al.. Low tumor necrosis factor-α levels predict symptom reduction during electroconvulsive therapy in major depressive disorder. Brain Behav. 2018;8 (4):e00933. doi: 10.1002/brb3.933. PubMed PMID:29670819 PubMed Central PMC5893337.
  9. Archer, M, Niemelä, O, Hämäläinen, M, Moilanen, E, Leinonen, E, Kampman, O et al.. The effects of adiposity and alcohol use disorder on adipokines and biomarkers of inflammation in depressed patients. Psychiatry Res. 2018;264 :31-38. doi: 10.1016/j.psychres.2018.03.073. PubMed PMID:29626829 .
  10. Solismaa, A, Kampman, O, Lyytikäinen, LP, Seppälä, N, Viikki, M, Mononen, N et al.. Genetic Polymorphisms Associated With Constipation and Anticholinergic Symptoms in Patients Receiving Clozapine. J Clin Psychopharmacol. 2018;38 (3):193-199. doi: 10.1097/JCP.0000000000000885. PubMed PMID:29620694 .
  11. Amare, AT, Schubert, KO, Tekola-Ayele, F, Hsu, YH, Sangkuhl, K, Jenkins, G et al.. Association of the Polygenic Scores for Personality Traits and Response to Selective Serotonin Reuptake Inhibitors in Patients with Major Depressive Disorder. Front Psychiatry. 2018;9 :65. doi: 10.3389/fpsyt.2018.00065. PubMed PMID:29559929 PubMed Central PMC5845551.
  12. Andre, K, Kampman, O, Viikki, M, Setälä-Soikkeli, E, Illi, A, Mononen, N et al.. BDNF and NRG1 polymorphisms and temperament in selective serotonin reuptake inhibitor-treated patients with major depression. Acta Neuropsychiatr. 2018;30 (3):168-174. doi: 10.1017/neu.2017.37. PubMed PMID:29310728 .

Search PubMed